Analytical Evaluations
Click on the publication title to view the full text (in pdf format).
In addition to our community-based research programs, our unit has also
conducted the following scientific evaluations on POCT devices for the
following tests:
Haemoglobin A1c (HbA1c)
Martin D, Shephard M, Freeman H, Jones TW, Davis E and Maguire G. Point-of-care
testing of HbA1c and blood glucose in a remote Aboriginal Australian community.
Medical Journal of Australia 2005; 182: 524-527.
Shephard M and Whiting M. Assessment
of the practicability and analytical performance of a point-of-care affinity
chromatography haemoglobin A1c analyser for use in the non-laboratory
setting. Annals of Clinical Biochemistry 2006; 43; 513-515.
Lipids
Shephard MDS and Tallis G. Assessment
of the point-of-care Cholestech Lipid Analyser for lipid screening in
Aboriginal communities. Australian Journal of Medical Science 2002;
23: 4-10.
Urine Albumin:Creatinine Ratio
Shephard MDS, Barratt L, Simpson-Lyttle W. Is
the Bayer DCA 2000 acceptable as a screening instrument for the early
detection of renal disease? Annals of Clinical Biochemistry 1999;
36: 393-394.
Creatinine
Mazzachi
B, Lavender K and Shephard MDS. Improved performance of the blood creatinine
module on the i-STAT point-of-care analyser. Poster presented at the 39th
Annual Scientific Meeting of the Australasian Association of Clinical
Biochemists, Auckland, New Zealand (October 2001). Abstract published
in the Clinical Biochemists Reviews 2001; 22: 82.
Mazzachi
B, Lavender K and Shephard MDS. An assessment of the i-STAT point-of-care
analyser for biochemical monitoring of renal disease in remote areas.
Poster presented at the 38th Annual Scientific Meeting of the Australasian
Association of Clinical Biochemists (November 2000). Abstract published
in the Clinical Biochemist Reviews 2000; 21: 115.
The following landmark paper has also been
published concerning analytical goals for common POCT used for diabetes
management:
Shephard
M. Analytical goals for point-of-care testing used for diabetes management
in Australian health care settings outside the laboratory. Point-of-Care:
The Journal of Near-Patient Testing and Technology 2006; 5: 177-185.
| |

Mark Shephard conducting a POCT evaluation in
the laboratory
|
|